Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial (Q46758980)
Jump to navigation
Jump to search
scientific article published on 11 February 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial |
scientific article published on 11 February 2008 |
Statements
1 reference
Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial (English)
1 reference
A Budaj
1 reference
DREAM Trial Investigators
1 reference
G R Dagenais
1 reference
H C Gerstein
1 reference
R Holman
1 reference
A Escalante
1 reference
T Hedner
1 reference
M Keltai
1 reference
E Lonn
1 reference
S McFarlane
1 reference
M McQueen
1 reference
K Teo
1 reference
P Sheridan
1 reference
J Bosch
1 reference
J Pogue
1 reference
S Yusuf
1 reference
11 February 2008
1 reference
1 reference
31
1 reference
5
1 reference
1007-1014
1 reference
Identifiers
1 reference
1 reference